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ABSTRACT
The study aimed to analyze the potential of okra to reduction blood glucose and MDA liver in strepto-
zotocin (STZ)-induced diabetic rats. Design experiment used in this study was pre and post test con-
trolled group design. The first step of this study was analyzed bioactive compound of okra extract. The 
next step was administired orally of okra extract to control and diabetic rats induced by streptozoto-
cin 50 mg/kgBW for 14 days. Sprague dawley rats were divided into six groups: normal control (N), 
diabetic control (DM), diabetic treated with green okra extract (GOE) with the dosage of 5 mg/kgBW 
quercetin and 10 mg/kgBW quercetin, diabetes treated with purple okra extract (POE) with the dosage 
of 5 mg/kgBW quercetin and 10 mg/kgBW quercetin. Blood glucose were measured each five days and 
malondialdehyde (MDA) liver in rats were measured in the end of intervention. The following results 
show that phenolic and quercetin of purple okra extract were higher (3.60%; 0.45 mg/g) than green okra 
extract (3.58%; 0.27 mg/g). Administration of GOE I, GOE II, POE I and POE II in diabetic rats showed 
significant (P<0.05) reduction in blood glucose level (115.25 mg/dl; 86 mg/dl; 180.75 mg/dl; 91 mg/dl) 
and improve level of MDA. These results suggest that intervention of okra extract based on quercetin 
compound show an antihyperglicemic potential and improve MDA level.
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INTRODUCTION
Diabetes mellitus (DM) is a chronic meta-
bolic disease resulting in an impaired metabolism 
of carbohydrate, protein and lipid which associat-
ed with insufficient seceretion of insulin that oc-
curs in type 1 DM or increased insulin resistance 
as characterictic of type 2 DM (ADA 2014). Type 
2 DM represents more than 90% of all cases of 
DM in the world. According to the International 
Diabetes Federation (IDF), the number of diabet-
ics reach 382 million in 2013 and this value is 
predicted to rise to around 592 million by 2035 
(IDF 2013).
Hyperglycemia condition can  increase ox-
idative stress by increasing the production of Re-
active oxygen species (ROS) by electron trans-
port chains in mitochondria characterized by the 
changes in glucose biochemistry and end-product 
of lipid peroxidation indicator i.e malondialde-
hyde (MDA) ( Gupta et al. 2009; Aouacheri et al. 
2014). Increasing oxidative stress be risk factor 
leads to insulin resistance, dyslipidemia, β cell 
dysfunction, impaired glucose tolerance and type 
2 DM (Tangvarasittichai 2015).
Epidemiological studies suggested that 
consumption of foods rich in bioactive com-
pounds as catechin in tea, anthocyanin in plants 
colored red, purple, blue, and quercetin com-
pound can reduce risk of diabetes, heart disease, 
obesity, hyperlipidemia, stroke and cancer (Xiao 
et al. 2011; Wedick et al. 2012; Damayanthi et 
al. 2013). Okra (Abelmoschus esculentus L.) also 
known as lady finger or gumbo, is a tropical veg-
etable that included in the Mallow family. Okra 
contains of many flavonoids compounds which 
have antioxidant activity (Liao et al. 2012; Ara-
pitsas et al. 2008).
The potential of okra (Abelmoschus escu-
lentu L) as antidiabetic has been demonstrated 
from some research. Antidiabetic potential of 
okra by following mechanism: improve uptake 
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glucose tissue (Prior et al. 2008), improve insu-
lin sensitivity (Sasaki et al. 2007), prevent lipid 
peroxidation (Oboh et al. 2014), promote liv-
er and pancreatic cell proliferation  and  act as 
α-glucosidase inhibitor (Babu et al. 2013). Re-
search conducted by Sabitha et al. (2013) have 
shown that administration of peel and seed okra 
extract with th dosage of 100 and 200 mg/kgBB 
significantly lowered in blood glucose levels and 
increase weight loss and prevent lipid peroxida-
tion in STZ-induced diabetic rats. Purple okra as 
a results of okra superior cultivation from  Zahira 
varieties. Some scientists studied green okra use-
ful in DM and some of them having antioxidant 
properties, while are studying purple okra useful 
still rarely done. Antioxidant potential of green 
okra and purple okra need to be intervention for 
DM treatment. The aim of the present study was 
analyzed the effect of green and purple okra ex-
tract as anti hyperglycemia agents and improve 
the level of  MDA liver in streptozotocin (STZ) 
induced diabetic rats.
METHODS
Design, location, and time
Pre and post test controlled group design 
were used for the experiment. This research held 
on February until September 2017. It took place 
in Food Chemistry and Nutrient Analysis Labora-
tory Community, Nutrition Department, Faculty 
of Human Ecology and SEAFAST Center Bogor 
Aglicultural University. In vivo stage were done 
at Animal Laboratory Management Unit (UPHL) 
Faculty of Veterinary IPB. MDA liver measure-
ment were conducted at Pathology Anatomy Lab-
oratory, Medical Faculty in Brawijaya University 
Malang. This research were got ethical cleareance 
from Animal Ethical Comittion LPPM IPB with 
number 63-2017 IPB.
Materials and tools
The main material used in this research is 
green okra from Naila varieties and purple okra 
from Zahira varieties was obtained from Prof. 
Muhammad Syukur Department of Agronomy 
and Horticulture of Bogor Agricultural Uni-
versity. 3 month old male Sprague Dawley rats 
obtained from the National Food and Drug Ad-
ministration Center BPOM Jakarta. Material used 
in the okra extraction is 70% methanol solution. 
Materials used for proximate analysis include 0.3 
ml Folin-Ciocaiteu, gallic acid standard solution 
for total phenolic analysis and quercetin stan-
dard solution for quercetin analysis. Equipments 
used in the making of okra extraction and proxi-
mate analysis were magnetic stirer Bellco glass.
inc (Vineland, USA), vacuum evaporator, freeze 
dryer, and spectrophotometry Optima SP-300 
(Japan), glass (Pyrex®), filter paper Whatman, 
micropipet 1000 µL and 10-100 µL, reaction tube 
(Schott Duran), centrifuge (Kokusan, Japan), col-
umn stationary phase HPLC, vortex, and water 
bath aquades (Julabo SW22, Japan). 
Material and equipment for animal main-
tenance were individual cage with cage area 33.5 
x 27 x 12 cm, husk, drink bottle 250 ml, digital 
scales Sigma, rats fed standard based on AIN-93 
formulation.  Material and equipment for diabetes 
induction were streptozotocin (STZ) from Sigma 
Chemical Co. (St. Louis, MO, USA), physiologi-
cal NaCl and syringe intraperitoneal injection 
(Terumo). Blood glucose were measured us-
ing glucometer (GlucoDr Korea) and glucostrip 
(GlucoDr Korea). Malondialdehyde (MDA) were 
analyzed using ketamine and xylazin mix solu-
tion, scalpel, surgical board for got liver organ. 
Procedures 
Okra extraction and preparation. 500 g 
green and purple okra (without separating be-
tween skin and seeds) were dried using freeze 
dryer vertical tipe Snijders scientific. Dried okra 
weighed and smoothed with blender. 10 g powder 
dried okra added with 500 ml 70% methanol solu-
tion in the Erlenmeyer continued with extraction 
gradually until obtained clearly residue. Filtrate 
evaporated with vacum evaporator. Okra extract 
weighed and analyzed bioactive compound total 
phenolic using spectrophotometry method (Liao 
et al. 2012) and quercetin compound analyzed 
using High Perfomance Liquid Chromatography 
(HPLC) method.
Quercetin analysis using HPLC method. 
0.5 g sample were diluted with MeOH 62.5% 
TBHQ (2 g/l) up to 20 ml. Sample solution were 
incorporated in Erlenmeyer added with 5 ml HCl 
6M then refluxed for 2 hours at  90oC. The ex-
tract were allowed to cool then filtered into 25 
ml measuring flask. A filtering were performed 
using 0.45µm filter paper whatman and were 
placed into 25 ml measuring flask diluted with 
aquades. 10 µL samples were injected into HPLC 
370 nm with comparison of ACN and K2HPO4 
0.025M column phase 25:75. Standard quercetin 
curve were read for 30 min, followed by injecting 
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10 μl samples into HPLC system for 30 min to 
obtain quercetin levels of okra extract (Hertog et 
al. 1995).
Streptozotocin (STZ) induction and rats 
maintenance. 24 rats were adapted for 14 days 
with standard feeding formulated based on AIN-
93 and allowed to drink water ad libitum. At day 
15 after adaptation, 4 rats were included in nor-
mal group (N) and 20 rats were performed intra-
peritoneal STZ induction. After overnight fasting 
(12-16 h), rats were injected intraperotoneally 
with single dose of STZ 50 mg/kgBW. The suc-
cess of diabetes induction was determined by 
measuring blood glucose levels after a 3-day 
STZ induction. When fasting glucose plasma 
(FPG) levels > 126 mg/dl were included in dia-
betic model rats groups (Jung et al. 2011). The 
diabetic model rats were divided into 5 random-
ized treatment groups including diabetes control 
(DM) ie untreated diabetic model rat, treatment 
group given green okra extract with the dosage of 
5 mg/kgBW quercetin (GOE I) and 10 mg/kgBW 
(GOE II ), treatment group given purple okra ex-
tract with the dosage of 5 mg/kgBW quercetin 
(POE I) and 10 mg/kgBW (POE II). The GOE 
and POE dissolved with Twin 1% were admin-
istered orally to the treatment group animals for 
14 days. Administration  of okra extract each day 
limited to maximum of 3.5 ml based on stomach 
capacity of rats were 10 ml/kgBW (Mc Connel et 
al. 2008). The dosage of 5 mg/kgBW quercetin 
on okra extract equals with consumption of  263 
g fresh okra for humans 70 kg, while the dosage 
of 10 mg/kgBB quercetin on okra extract was 
equivalent to the consumption of 526 g resh okra. 
The dosage of okra extract was based on querce-
tin compound present in okra based on Gomes et 
al. (2015) research.
 Measurement of fasting plasma glu-
cose (FPG) and malondialdehyde of liver lev-
els. Blood glucose was measured every five days 
start from 0 day after rats showed diabetic con-
dition by induced STZ.  After overnight fasting 
(rats were deprived of food for 12-16 h but al-
lowed to water), rats were collected blood from 
vein tail. In the end of intervention (day 15) rats 
were general anesthesia using ketamine: 75 mg/
kgBB and xylazine: 5 mg/kgBB sollution. Liver 
organ were abtained from rats surgery. Measure-
ment of malondialdehyde level on liver organ us-
ing thiobarbiturat acid test (TBA) (Aulanni’am et 
al. 2012). 
Data analysis
Data was processed and analyzed using 
Microsoft Excel 2010 and SPSS software ver-
sion 16.0. Statistical analysis were assessed by 
one-way analyses of variance (ANOVA). Pre-
test and post-test data of results were assessed 
by paired sample t-test to analyzed differences 
data between before and after intervention. If 
there is differences between data sets (significant 
on p<0.05), further test conducted by Duncan’s 
multiple-range test. 
RESULTS AND DISCUSSION
Bioactive compound of green okra and purple 
okra extract. 
Initial stages in this study is to analyze 
bioactive compound of green okra extract (GOE) 
and purple okra extract (POE) including total 
phenolic, and quercetin. GOE contents quercetin 
compound 0.27 mg/g, while quercetin compound 
of POE were higher 0.45 mg/g  (Table 1). Quer-
cetin is the major flavonoid in Okra where 70% 
total antioxidant compound in okra comes due 
to the quercetin derivative (Shui & Peng 2004). 
Quercetin content in GOE and POE were higher 
when compared with torbangun leaves extract 
(Coleus amboinicus Lour) 0.02 mg/g (Trini et al. 
2015). 
Table 1. Bioactive compound of GOE and POE 
Bioactive compound GOE POE
Total Phenolic (%) 3.58 3.60 
Quercetin (mg/g) 0.27 0.45
Scientific research about bioactive content 
of okra extract has been done. Some studies have 
shown that the skin and okra seeds contain poly-
phenol components such as hydroxynamic acid 
and its derivatives, catechins, quercetin deriva-
tives, and flavonols (Shui & Peng 2004; Huang et 
al. 2007). The results showed that total phenolic 
of POE and GOE are similar almost, while quer-
cetin on POE was higher than GOE. Okra skin 
contains polyphenols from hydroxynamic acid 
group and quercetin derivatives in the amount 
of 0.2 mg/g and 0.3 mg/g samples respectively 
(Arapitsas et al. 2008). In this study using fresh 
okra without separated between skin and seeds. 
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The highest polyphenols compound in okra can 
found in seeds with total phenolic of 29.5%, while 
in skin 1.25% (Fan et al. 2014). α-glucosidase 
activity in okra leaf extract and okra seed is quite 
large (IC50=142.69 μg/ml; 150.47 μg/ml), while 
α-amylase activity (IC50=132.63 μg/ml; 147.23 
μg/ml) (Sabitha et al. 2012). α-glucosidase and 
α-amylase activity using IC50 method defined as 
the ability of  okra extract to inhibit 50% break-
down of carbohydrates into glucose, this activity 
plays important role in the antidiabetic mecha-
nism in managing increased blood glucose.
Effect of okra extract intervention on blood 
glucose 
The mean fasting plasma glucose (FPG) of 
treatment group at  pre-intervention  were 210.25 
to 285 mg / dl, 14 days after oral administration 
of okra extract (green and purple) FPG  ranged 
from 100.25 to 125.25 mg/dl (Table 2). 14-days 
after POE treatment, significantly decreased  the 
FPG in diabetic rats (p <0.05). GOE treatment 
group also showed a decrease in FPG compa-
rable amount  to the normal range although not 
significant based on different Paired t-test. From 
preliminary test results of okra extract known 
quercetin in POE was higher than GOE. The ma-
jor flavonoid in okra is quercetin showed act as 
an antidiabetic potency (Fan et al. 2014).
Flavonoids have done antioxidant activity 
by scavenging ROS (Reactive Oxygen Species) 
and RNS (Reactive Nitrogen Species) resulting 
from diabetogenic compounds ie STZ (Fuhrman 
& Aviram 2001). The major polyphenolic groups 
of flavonoids, tannins and phenolic acids play a 
Anjani et al.
role in carbohydrate metabolism by inhibition 
of α-glucosidase and α-amylase responsible for 
digestion of starch into glucose, leading to an in-
creased the blood glucose (Iwai 2008: Tadera et 
al. 2006) . Decrease in FPG on treatment group 
of okra extract (green or purple) due to quercetin 
compound  in okra showed antioxidant activity 
by reduction  free radicals  from STZ. When free 
radicals can be scavenge will cause the insulin 
receptors in beta cells become active and were 
effectively made glucose can be used by cells as 
energy and cause decreased gluconeogenesis, as 
a result FPG levels go through decrease. Regula-
tion of carbohydrate metabolism by polypheno-
lics is also due to an increase of glycolysis and 
glucose oxidation in the body that can improve 
glucose homeostasis and insulin resistance (Ba-
hadoran et al. 2013).
In vitro studies showed that polyphenolic 
quercetin may increase insulin production, glu-
cose availability in muscle cells and adipocytes 
through GLUT4 glucose transporter transloca-
tion to plasma membranes thus inducing the 
AMP-activated protein kinase (AMPK)  pathway 
(Zhang et al. 2011; Park et al. 2007 ). AMPK is 
an energy cellular sensor as a stimulation of glu-
cose uptake to increase of glucose uptake as an 
energy store, when AMPK pathway become ac-
tive is considered a new mechanism  in the role of 
treatment of obesity, type 2 DM, metabolic syn-
drome (Towler 2007).
POE group with the dosage of 5 mg/
kgBW quercetin showed that greatest effect on 
decreases of  FPG compared with other treatment 





post intervention  p ∆ FPG
Mean ± SEM (mg/dl) Mean ± SEM (mg/dl)
Normal 84.25 ± 5.. 82.75 ± 5.39 0.678 -1.50 ± 3.28
DM 319.00 ± 71.04a 375.00 ± 70.60b 0.316 54.25 ± 47.95b
GOE I 215.50 ± 50.34a 100.25 ± 8.32a 0.074 -115.25 ± 42.86a
GOE II 210.25 ± 32.13a 124.25 ±34.26a 0.061 -86.00 ± 29.45a
POE I 284.50 ± 50.77a 103.75 ± 7.09a 0.029* -180.75 ± 45.65a
POE II 236.00 ± 71,89a 145.00 ± 58.43a 0.009* -91 ± 14.80a
p 0.0084** 0.002** 0.009**
*) Differences test using Paired t-test, significant difference on p<0.05, **) ANOVA followed by Duncan’s multiple range test, 
     significant on p<0.05.
Table 2. Fasting plasma glucose (FPG) in rats pre and post intervention 
J. Gizi Pangan, Volume 13, Number 1, March 2018                                                                        51
Potential of okra extract on blood glucose and MDA level
didn’t showed  better effect  on blood glucose 
levels because of administration  high dosage of 
certain bioactive compounds such as flavonoids 
can be prooxidant and trigger an increase in ROS 
by autoresidation and altering  redox reactions 
(Bouayed & Bohn 2010; Iwasaki et al. 2011). 
All of the treatment group had a significant de-
creases of FPG compared with DM group, but the 
decrease of FPG between treatment groups was 
not significantly different or relatively similar 
and close to FPG range in normal group. The de-
crease of FPG levels with administration of okra 
extract was due to quercetin compound  in okra. 
Oral administration of quercetin in STZ-induced 
diabetic rats has an effect  decreasing in serum 
glucose and viability of pancreatic β cells by in-
creasing the natural antioxidant system and inhi-
bition of lipid peroxidation (Yin et al. 2011). 
Effect of okra extract intervention on malon-
dialdehyde of liver
In this study different interventions showed 
that significant changes (p<0.05) on MDA levels 
rats. MDA levels after 14 days of treatment in 
DM group were significantly different with mean 
MDA levels of  normal and treatment groups 
(Table 3). 
ter 14 days the intervention compared to a control 
group of diabetes, shown that okra extract based 
on quercetin compound reduced  level of MDA 
in STZ induced diabetic rats. Antioxidant activ-
ity on the major flavonoid in okra that is querce-
tin compound due to an aromatic hydroxyl group 
which as ROS and RNS scavenger by inhibiting 
peroxidation reaction which leads to formation 
of final products in lipids peroxidation (du Thie 
& Crozier 2000; Moskaug et al. 2004). 
Polyphenols compounds have antioxidant 
activity as free radical scavenger by direct inter-
action with cellular receptors as a key of redox 
stages resulting in modified redox reactions and 
triggering a series of redox-dependent reactions 
(Scalbert et al. 2005). In vivo studies conducted 
by Oboh et al. (2014) reported that quercetin 
significantly inhibited the activity of α-amylase 
and α-glucosidase which suppressed the rise of 
blood glucose thus inhibiting lipid peroxidation 
process and pancreatic cell destruction. 
The mean data of MDA levels showed that 
group receiving GOE or POE intervention with 
the dosage of 5 mg/kgBW caused the change of 
MDA level close to the range MDA levels of 
normal group. The mean level of MDA in GOE 
and POE treatment group with the dosage of 10 
mg/kgBW was significantly different with mean 
level of MDA in DM group, but the change of 
MDA level given better effect compared with the 
dosage of 5 mg/kgBW. 
Intervention of POE based on quercetin 
compound at the dosage of 5 mg/kgBW shows 
that highest decrease level of MDA compared 
with other treatment groups after 14 days. Quer-
cetin  treatment could act as antioxidant and pro-
oxidant depending on the concentration given. 
At low concentrations of quercetin given protec-
tive effect on DNA damage (in vitro) in human 
lymphocytes and prevent occurrence of stress 
oxidative, but high concentration of quercetin 
with the dosage of 30 μM caused cytotoxicity ef-
fect (Spencer et al. 2003; Wilms et al. 2005).
CONCLUSION
Intervention of okra extract (green okra 
and purple okra) based on quercetin compound 
showed reduction on blood glucose levels and 
improved level of MDA liver. Purple okra extract 
significantly lowered blood glucose in strepto-
zotocin induced diabetic rats.
High levels of MDA in DM control due to 
the condition of diabetes caused  insulin levels 
low as a result of  β-oxidation  initiation fatty ac-
ids and the accumulation of free radicals in body 
that produce lipid peroxidation products (Annie 
et al. 2005).The mean levels of MDA in treat-
ment group showed significant improvement af-
Table 3. Malondialdehyde (MDA) of liver level 
              on post intervention 
Groups
Malondialdehyde (MDA) level
Mean ± SEM (ng/ml)
Normal 148.00 ± 2.22
DM 227.25 ± 3.07c
GOE I 164.50 ± 8.87ab
GOE II 186.88 ± 10.04b
POE I 156.50 ± 10.05a
POE II 182.00 ± 7.41ab
p 0.000*
* ANOVA followed by Duncan’s multiple range test, signifi-
cant (p<0.05)
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Further research is needed on  influence 
the dosage of okra extract based on quercetin 
compound  in a variety of levels from low dos-
age up to high dosage (more than 10 mg/kgBW) 
to know  the effects and characters of anti/pro-
oxidants quercetin of okra.
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